Patients with metabolic liver diseases may benefit from supplements of a common gut bacterium, a small study suggests.
The year 2023 has been a productive year for gut microbiome research. Read about the most relevant advances in translational and clinical gut microbiome research from the last 12 months, selected by the Gut Microbiota for Health editorial team.
Alterations in the gut microbiome composition and functions are emerging as a potential target for managing IBS. Discover how microbiota-modifying treatments, including prebiotics, probiotics, antibiotics, and fecal microbiota transplantation, hold promise in alleviating symptoms of this vexing condition.
Reduced red meat intake and gut microbial metabolite indole-3-acetate linked to better insulin resistance after gastric bypass, new study finds
8 Jan 2024by Joël Doré, Andreu Prados
The gut microbiome has been involved in reducing adiposity in patients with obesity after gastric bypass. New research suggests that food intake, tryptophan metabolism, and gut microbiota composition can explain the glycemic improvement observed in patients after Roux-en-Y gastric bypass.
Protist Tritrichomonas arnold protects against viral-induced gluten intolerance
18 Dec 2023by Heather Galipeau, Mark Wulczynski
Celiac disease is a chronic immune-mediated enteropathy that may be unleashed by enteric viral infections. However, new findings in mice identified a commensal protist, Tritrichomonas arnold, that protects against reovirus-induced intolerance to gluten by counteracting virus-induced proinflammatory dendritic cell activation.
Where are we on microbiome-based therapies in disorders of gut-brain interaction?
4 Dec 2023by Andreu Prados, Rene van den Wijngaard
NeuroGASTRO 2023, the leading meeting in Europe held by ESNM on the latest developments in neurogastroenterology, digestive motility, and disorders of gut-brain interaction, took place from August 31st to September 2nd, 2023. Find out more about the main takeaways from the role of fecal microbiota transplants, microbial consortia and probiotics in disorders of gut-brain interaction picked up by GMFH editors (Part 2).
Osteomicrobiology reveals a promising link between gut microbiota and osteoporosis prevention. New research highlights microbial strains influencing bone density, paving the way for targeted therapies. Further investigations will clarify this gut-bone axis and its potential in skeletal health.
Secure your spot! Washington D.C. to host 12th edition of the GMFH World Summit
16 Nov 2023by GMFH Editing Team
The 12th Gut Microbiota for Health World Summit will take place on March 23 and 24, 2024 in Washington D.C., USA, and remotely via livestream. Discover the scientific program and workshop sessions, which will focus on manipulations of human gut microbiome in health and disease.
Research highlights from NeuroGASTRO 2023: food, mast cells, eosinophils and gut barrier in disorders of gut-brain interaction
6 Nov 2023by Andreu Prados, Rene van den Wijngaard
NeuroGASTRO 2023, the leading meeting in Europe held by ESNM on the latest developments in neurogastroenterology, digestive motility, and disorders of the gut-brain interaction, took place from August 31st to September 2nd, 2023. Find out more what the latest research says about the involvement of the intestinal microbiota, mast cells, eosinophils and gut barrier in disorders of gut-brain interaction and dietary considerations in their management picked up by GMFH editors (Part 1).
Diagnosing IBS and targeting gut microbiota and metabolites to improve symptoms
18 Oct 2023by Andrea Costantino
Chronic abdominal pain, diarrhea, constipation, and bloating are common gastrointestinal symptoms. While a structural or an organic disease can be suspected because of the symptoms and is often easy to be diagnosed by endoscopy or imaging methods, sometimes gastrointestinal symptoms are not related to any alteration that may be seen through diagnostic techniques, and consequently have been classified under the umbrella of “disorders of gut-brain interaction”.